Market Cap 320.62M
Revenue (ttm) 0.00
Net Income (ttm) -138.20M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,507,800
Avg Vol 2,132,606
Day's Range N/A - N/A
Shares Out 119.63M
Stochastic %K 27%
Beta 1.28
Analysts Strong Sell
Price Target $11.60

Company Profile

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company's lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also devel...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 822 5500
Fax: 650 636 9773
Address:
1400 Sierra Point Parkway, Building C Suite 200, Brisbane, United States
Thomas105
Thomas105 Nov. 14 at 11:24 PM
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:45 PM
Hedge Alert Live - Protect Your Portfolio Contract: $ANNX $3.00 Put · NOV 21, 2025 Exp Entry Price: $0.25 - $0.95 Exit Price Target: $0.38 Profit Margin: +52% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Tigerpicko
Tigerpicko Nov. 14 at 6:09 PM
$ANNX $ANNX stock companies now recommending Annexon as a major growth company stating minimum increase of 54.7% per year over the next several years , as lve said previously it’s a stock moving fast over the next 3 months
1 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 8:04 AM
Hedge Alert Live - Protect Your Portfolio Contract: $ANNX $3.00 Put · NOV 21, 2025 Exp Entry Price: $0.25 - $0.50 Exit Price Target: $0.38 Profit Margin: +53% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Sly15
Sly15 Nov. 13 at 9:05 PM
$ANNX tomorrow the shares will be issued, going to take a couple weeks for the price to stabilize from the dilution.
0 · Reply
Thomas105
Thomas105 Nov. 13 at 8:43 PM
$ANNX dont believe the news
0 · Reply
raj3406
raj3406 Nov. 13 at 3:14 PM
$ANNX I’m loading around $2.60. The $75M raise tells me someone is expecting a move—either they want to take profits on upcoming news (which likely lands sooner rather than later so they can unload), or they’re positioning for a bigger long-term return if ANNX secures approval. Either way, accumulating at these levels carries less downside risk in my opinion, as long as you manage the position properly.
0 · Reply
Tigerpicko
Tigerpicko Nov. 13 at 2:58 PM
$ANNX when public offerings are launched, some stocks takes hit as they are years away from Commercialization, not this one this one is ready to explode, Looking forward to January however before that Oral presentation in December, BLA January could be before institutional released today many plus points near pre market sales or collaboration with pharmaceutical companies on ANX005 all positive now runway cash beyond 2027 Q1
0 · Reply
OpenOutcrier
OpenOutcrier Nov. 13 at 2:08 PM
$ANNX (-8.5% pre) Annexon prices $75 million stock offering at $2.60 per share https://ooc.bz/l/84444
0 · Reply
Sly15
Sly15 Nov. 13 at 1:52 PM
$ANNX new range $2.10- $2.80 near term taking into account dilution.
0 · Reply
Latest News on ANNX
Annexon: Lead GBS Therapy Stokes Near-Term Potential

Jul 14, 2025, 12:47 PM EDT - 4 months ago

Annexon: Lead GBS Therapy Stokes Near-Term Potential


Annexon Announces Proposed Public Offering of Common Stock

Jun 4, 2024, 5:06 PM EDT - 1 year ago

Annexon Announces Proposed Public Offering of Common Stock


Annexon: ANX007 Advances Forward With Stellar Endpoint

Dec 23, 2023, 12:00 PM EST - 2 years ago

Annexon: ANX007 Advances Forward With Stellar Endpoint


Thomas105
Thomas105 Nov. 14 at 11:24 PM
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:45 PM
Hedge Alert Live - Protect Your Portfolio Contract: $ANNX $3.00 Put · NOV 21, 2025 Exp Entry Price: $0.25 - $0.95 Exit Price Target: $0.38 Profit Margin: +52% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Tigerpicko
Tigerpicko Nov. 14 at 6:09 PM
$ANNX $ANNX stock companies now recommending Annexon as a major growth company stating minimum increase of 54.7% per year over the next several years , as lve said previously it’s a stock moving fast over the next 3 months
1 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 8:04 AM
Hedge Alert Live - Protect Your Portfolio Contract: $ANNX $3.00 Put · NOV 21, 2025 Exp Entry Price: $0.25 - $0.50 Exit Price Target: $0.38 Profit Margin: +53% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Sly15
Sly15 Nov. 13 at 9:05 PM
$ANNX tomorrow the shares will be issued, going to take a couple weeks for the price to stabilize from the dilution.
0 · Reply
Thomas105
Thomas105 Nov. 13 at 8:43 PM
$ANNX dont believe the news
0 · Reply
raj3406
raj3406 Nov. 13 at 3:14 PM
$ANNX I’m loading around $2.60. The $75M raise tells me someone is expecting a move—either they want to take profits on upcoming news (which likely lands sooner rather than later so they can unload), or they’re positioning for a bigger long-term return if ANNX secures approval. Either way, accumulating at these levels carries less downside risk in my opinion, as long as you manage the position properly.
0 · Reply
Tigerpicko
Tigerpicko Nov. 13 at 2:58 PM
$ANNX when public offerings are launched, some stocks takes hit as they are years away from Commercialization, not this one this one is ready to explode, Looking forward to January however before that Oral presentation in December, BLA January could be before institutional released today many plus points near pre market sales or collaboration with pharmaceutical companies on ANX005 all positive now runway cash beyond 2027 Q1
0 · Reply
OpenOutcrier
OpenOutcrier Nov. 13 at 2:08 PM
$ANNX (-8.5% pre) Annexon prices $75 million stock offering at $2.60 per share https://ooc.bz/l/84444
0 · Reply
Sly15
Sly15 Nov. 13 at 1:52 PM
$ANNX new range $2.10- $2.80 near term taking into account dilution.
0 · Reply
Tigerpicko
Tigerpicko Nov. 13 at 12:41 PM
$ANNX keep adding this is an opportunity , I’m doubling down another 100k going in
0 · Reply
Tigerpicko
Tigerpicko Nov. 13 at 12:37 PM
$ANNX 6months up 60.45%
0 · Reply
PrivateTrading
PrivateTrading Nov. 13 at 12:13 PM
$ANNX YTD ANNX -45% SP 500 +16% NASDAQ 100 +21%
1 · Reply
DonCorleone77
DonCorleone77 Nov. 13 at 11:50 AM
$ANNX Annexon 25.1M share Spot Secondary priced at $2.60
0 · Reply
11__11
11__11 Nov. 13 at 11:17 AM
$ANNX fill me 2.49 bid is up now get out while you can i will take your bags safely
0 · Reply
Stmkr
Stmkr Nov. 13 at 5:52 AM
$ANNX What are the chances FDA won't ask for an RCT?? Slim I would say. And I dont understand why they are not doing it. It could be IVIG/PA+placebo vs placebo/sham+ANX005. Not following the company. What is the rationale for not conducting such an RCT and attempting approval based on a matched cohort study and a Philipines-Banglandesh RCT?
3 · Reply
Tigerpicko
Tigerpicko Nov. 13 at 5:39 AM
$ANNX Happening as it did 2 years ago, offering IPO share price went from similar position now $2.58 to $6.8 very quickly, major difference in pipeline this time, this is major and the start of going to market with enhanced costs as per earnings report under risks due to market increases and new hurdles to get over for me this is another opportunity to purchase more stock as it won’t be long until jumps to $6 - bring it on as l said January will be up there and beyond
0 · Reply
PrivateTrading
PrivateTrading Nov. 13 at 1:52 AM
$ANNX If a pharmaceutical company was interested in ANX005, then why have a public offering of $75 million of shares of common stock or pre-funded warrants to purchase shares of its common stock? It leads me to believe that pharmaceutical companies may not be interested in ANX005. For a company with a tenuous cash position, it may not be financially prudent to hire a sales force and spend money on marketing to sell ANX005. The cash position is down to 12 months.
0 · Reply
PrivateTrading
PrivateTrading Nov. 13 at 12:12 AM
$ANNX In the earnings call management said that they would seek collaborations of nondilutive financing. The $75M warrant deal is not consistent with their statements. Management's integrity should be called into question. Perhaps grounds for a law suit.
2 · Reply
Sly15
Sly15 Nov. 12 at 11:07 PM
$ANNX he needs time. I’m not surprised. Selling a license when you haven’t submitted or had anything approved just seems like a tough sell to me. I think this is heading below $2. Need to wait for the fallout before jumping back in. I am still a believer in their technology, and believe they will ultimately prevail, but heading for some short term pain here.
1 · Reply
raj3406
raj3406 Nov. 12 at 10:52 PM
$ANNX I really thought they would do the offering after the MAA submission or BLA submission.
2 · Reply
Lightening_strikes
Lightening_strikes Nov. 12 at 9:49 PM
$ANNX junk
1 · Reply